The drug has attracted intense interest because it is one of the first compounds aiming to blockprotein clumps called amyloid from accumulating in the brains of Alzheimer's patients.
He foresaw a new weapon against cancer--block the protein and tumors may be unable to proliferate--but the finding was so obscure that even his boss was skeptical.